Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1951 2
1956 1
1958 1
1959 2
1961 4
1962 4
1963 7
1964 14
1965 9
1966 17
1967 14
1968 14
1969 27
1970 16
1971 12
1972 13
1973 19
1974 24
1975 23
1976 17
1977 23
1978 28
1979 21
1980 19
1981 35
1982 38
1983 34
1984 39
1985 34
1986 43
1987 51
1988 47
1989 57
1990 56
1991 63
1992 59
1993 56
1994 88
1995 62
1996 74
1997 70
1998 81
1999 89
2000 101
2001 106
2002 99
2003 127
2004 118
2005 119
2006 131
2007 113
2008 119
2009 125
2010 146
2011 155
2012 173
2013 163
2014 151
2015 159
2016 158
2017 194
2018 149
2019 194
2020 220
2021 276
2022 240
2023 259
2024 247
2025 262
2026 120

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,318 results

Results by year

Filters applied: . Clear all
Page 1
Exploring Definitions and Predictors of Severe Asthma Clinical Remission after Biologic Treatment in Adults.
Perez-de-Llano L, Scelo G, Tran TN, Le TT, Fagerås M, Cosio BG, Peters M, Pfeffer PE, Al-Ahmad M, Al-Lehebi RO, Altraja A, Bergeron C, Bjermer LH, Bjerrum AS, Bulathsinhala L, Busby J, Cano Rosales DJ, Canonica GW, Carter VA, Charriot J, Christoff GC, Denton EJ, Dorscheid DR, Fernandez Sanchez MJ, Fonseca JA, Gibson PG, Goh CYY, Heaney LG, Heffler E, Hew M, Iwanaga T, Katial R, Koh MS, Kuna P, Larenas-Linnemann DES, Lehtimäki L, Mahboub B, Martin N, Matsumoto H, Menzies-Gow AN, Papadopoulos NG, Popov TA, Porsbjerg CM, Patel P, Rhee CK, Sadatsafavi M, Taillé C, Torres-Duque CA, Tsai MJ, Ulrik CS, Upham JW, von Bülow A, Wang E, Wechsler ME, Price DB. Perez-de-Llano L, et al. Among authors: matsumoto h. Am J Respir Crit Care Med. 2024 Oct 1;210(7):869-880. doi: 10.1164/rccm.202311-2192OC. Am J Respir Crit Care Med. 2024. PMID: 38701495 Free PMC article.
Medication Optimization Protocol Efficacy for Geriatric Inpatients: A Randomized Clinical Trial.
Ie K, Hirose M, Sakai T, Motohashi I, Aihara M, Otsuki T, Tsuboya A, Matsumoto H, Hashi H, Inoue E, Takahashi M, Komiya E, Itoh Y, Machino R, Tsuchida T, Albert SM, Ohira Y, Okuse C. Ie K, et al. Among authors: matsumoto h. JAMA Netw Open. 2024 Jul 1;7(7):e2423544. doi: 10.1001/jamanetworkopen.2024.23544. JAMA Netw Open. 2024. PMID: 39078632 Free PMC article. Clinical Trial.
Durvalumab with etoposide and carboplatin for patients with extensive-stage small cell lung cancer and interstitial lung disease: A multicenter, open-label prospective trial.
Shibaki R, Fujimoto D, Miyauchi E, Tsukita Y, Nakachi I, Arai D, Sakata Y, Shingu N, Shimokawa T, Kijima T, Tamiya M, Kawana S, Hara S, Saito G, Sato Y, Yokoyama T, Sakata S, Taniguchi Y, Hata A, Matsumoto H, Yamaguchi T, Yamamoto N. Shibaki R, et al. Among authors: matsumoto h. Lung Cancer. 2024 Oct;196:107958. doi: 10.1016/j.lungcan.2024.107958. Epub 2024 Sep 19. Lung Cancer. 2024. PMID: 39312871 Clinical Trial.
Real-world usage and response to gefapixant in refractory chronic cough.
Matsumoto H, Kanemitsu Y, Ohe M, Tanaka H, Terada K, Nishi K, Atsuta R, Hara J, Saito J, Ohmichi M, Ishizuka T, Nishiuma T, Inoue H, Watanabe N, Nagano T, Ueda T, Ogawa H, Endo S, Suzuki T, Kita T, Fujimori K, Ishiura Y, Fujimura M, Niimi A. Matsumoto H, et al. ERJ Open Res. 2025 Jul 7;11(4):01037-2024. doi: 10.1183/23120541.01037-2024. eCollection 2025 Jul. ERJ Open Res. 2025. PMID: 40630384 Free PMC article.
Serum VEGF-A as a biomarker for the addition of bevacizumab to chemo-immunotherapy in metastatic NSCLC.
Tanaka K, Sugisaka J, Shiraishi Y, Watanabe Y, Daga H, Azuma K, Nishino K, Mori M, Ota T, Saito H, Hata A, Sakaguchi T, Kozuki T, Akamatsu H, Matsumoto H, Tachihara M, Wakuda K, Sato Y, Ozaki T, Tsuchiya-Kawano Y, Yamamoto N, Nakagawa K, Okamoto I. Tanaka K, et al. Among authors: matsumoto h. Nat Commun. 2025 Mar 22;16(1):2825. doi: 10.1038/s41467-025-58186-7. Nat Commun. 2025. PMID: 40121197 Free PMC article. Clinical Trial.
A novel plasma p-tau181 assay as a specific biomarker of tau pathology in Alzheimer's disease.
Tagai K, Tatebe H, Matsuura S, Hong Z, Kokubo N, Matsuoka K, Endo H, Oyama A, Hirata K, Shinotoh H, Kataoka Y, Matsumoto H, Oya M, Kurose S, Takahata K, Ichihashi M, Kubota M, Seki C, Shimada H, Takado Y, Kawamura K, Zhang MR, Soeda Y, Takashima A, Higuchi M, Tokuda T. Tagai K, et al. Among authors: matsumoto h. Transl Neurodegener. 2024 Sep 3;13(1):44. doi: 10.1186/s40035-024-00439-4. Transl Neurodegener. 2024. PMID: 39238067 Free PMC article. No abstract available.
5,318 results